Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

The document covers various male health issues, their causes, treatments, and related conditions.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

PCOS may be influenced by factors in the blood, not just the ovaries.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Fadrozole and Finasteride change frog sex ratios and cause intersex animals with altered gene expressions.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Androgen deprivation therapy for prostate cancer can cause sexual, physical, and psychological side effects, and doctors should manage these carefully.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Dietary changes, including weight loss and a balanced diet, are important for managing PCOS, especially in overweight women.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Skin health and diseases are closely linked to metabolic processes.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Gene mutations can cause problems in male genital development.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Long-term finasteride use doesn't change bone density or metabolism.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

The girl's unexpected pubic hair growth led to a diagnosis different from complete androgen insensitivity syndrome.